APT(SH:688617) Sou Hu Cai Jing·2025-10-25 18:46Core Points - Huatai Medical (688617) closed at 324.0 CNY on October 24, 2025, up 5.29% from 307.71 CNY the previous week, with an intraday high of 337.2 CNY and a low of 307.1 CNY during the week [1] - The current market capitalization of Huatai Medical is 45.688 billion CNY, ranking 4th out of 126 in the medical device sector and 385th out of 5160 in the A-share market [1] - As of September 30, 2025, the number of shareholders increased to 5,690, a rise of 26.25% from June 30, 2025, with an average shareholding of 24,800 shares per shareholder [1][4] Shareholder Changes - The number of shareholders as of September 30, 2025, is 5,690, reflecting a 26.25% increase from the previous quarter [4] - The average number of shares held per shareholder decreased from 31,300 shares to 24,800 shares, with an average shareholding value of 7.8494 million CNY [1][4] Financial Performance - For the third quarter of 2025, Huatai Medical reported a revenue of 654 million CNY, representing a year-on-year growth of 24.77% [4] Company Announcements - Huatai Medical plans to increase its expected amount of daily related transactions for 2025 to a total of 18.62 million CNY, including 12.62 million CNY for transactions with Mindray Bio-Medical Electronics Co., Ltd. [2][4] - The increase in transaction amounts has been approved by the company's board of directors and does not require shareholder meeting approval, ensuring compliance with fair pricing and independence [2]